Poland· PL-100487683

Invitaxon

A vitamin b1 in combination with vitamin b6 and/or vitamin b12 product containing benfotiaminum + pyridoxini hydrochloridum + cyanocobalaminum, registered in Poland by Adamed Pharma S.A.. The same ATC class is registered in 7 of our 19 countries.

ATC A11DB

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedInvitaxonATCA11DBREGISTER NO.PL-100487683PACKS LISTED7CHECKEDSeptember 27, 2026

Where it is registered

Benfotiaminum + pyridoxini hydrochloridum + cyanocobalaminum is registered in 7 of 19 countries.

Countries holding a registration under ATC A11DB (vitamin b1 in combination with vitamin b6 and/or vitamin b12), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Benfotiaminum + pyridoxini hydrochloridum + cyanocobalaminum · ATC A11DB

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Icelandprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Benfotiaminum + Pyridoxini hydrochloridum + Cyanocobalaminum
Manufacturer
Adamed Pharma S.A.
Country
Poland (PL)
ATC code
A11DB
ATC class
Vitamin B1 in combination with vitamin B6 and/or vitamin B12
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

  • gtin
    05909991561574
  • gtin
    05909991561581
  • gtin
    05909991561598
  • gtin
    05909991561604
  • gtin
    05909991561611
  • gtin
    05909991561628
  • gtin
    05909991561635

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Benfotiaminum + pyridoxini hydrochloridum + cyanocobalaminum in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All benfotiaminum + pyridoxini hydrochloridum + cyanocobalaminum products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Bulgaria · Бевит Трио, Бенфоневровит
  • Czechia · Milgamma N, Neuromultivit Neo
  • Germany · Neuromultivit
  • Estonia · Neuromultivit
  • Hungary · Milgamma N, Neurogerlon Neo
  • Lithuania · Fenglavit, Milgamma N
  • Latvia · Fenglavit, Milgamma N
  • Romania · Milgamma N, Neuromultivit Neuro
  • Slovenia · Neuromultivit
  • Slovakia · Milgamma N, Tiadel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/946d8ef3-0cd6-4a54-bfea-b6033ae3c21b
GET /v1/drugs/946d8ef3-0cd6-4a54-bfea-b6033ae3c21b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "150 mg + 50 mg + 0,2 mg",
  "packaging": "05909991561574 ¦ Rp ¦ 159497\n30 tabl.\n05909991561581 ¦ Rp ¦ 159498\n45 tabl.\n05909991561598 ¦ Rp ¦ 159499\n60 tabl.\n05909991561604 ¦ Rp ¦ 159500\n90 tabl.\n05909991561611 ¦ Rp ¦ 159501\n100 tabl.\n05909991561628 ¦ Rp ¦ 159502\n105 tabl.\n05909991561635 ¦ Rp ¦ 159503\n120 tabl.",
  "substance": "Benfothiaminum 150 mg + Pyridoxini hydrochloridum 50 mg + Cyanocobalaminum 0.2 mg",
  "common_name": "Benfotiaminum + Pyridoxini hydrochloridum + Cyanocobalaminum",
  "pl_product_id": "100487683",
  "pozwolenie_nr": "28811",
  "auth_procedure": "DCP",
  "authorisation_validity": "2030-01-13"
}

See everything about benfotiaminum + pyridoxini hydrochloridum + cyanocobalaminum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.